scispace - formally typeset
R

Richard J. Rodeheffer

Researcher at Mayo Clinic

Publications -  244
Citations -  31533

Richard J. Rodeheffer is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Heart failure & Population. The author has an hindex of 74, co-authored 240 publications receiving 29582 citations. Previous affiliations of Richard J. Rodeheffer include University of British Columbia & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

TL;DR: In the community, systolic dysfunction is frequently present in individuals without recognized CHF and diastolic dysfunction as rigorously defined by comprehensive Doppler techniques is common, often not accompanied by recognizedCHF, and associated with marked increases in all-cause mortality.
Journal ArticleDOI

Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure

TL;DR: Questionnaire data are of greatest value in life-threatening, acute-onset diseases and chronic disorders requiring ongoing management and are more accurate in young women and better-educated subjects.
Journal ArticleDOI

Plasma brain natriuretic peptide concentration: impact of age and gender.

TL;DR: Investigation of the effects of age and gender on plasma brain natriuretic peptide concentration in a population-based study confirmed that discriminatory values for BNP for detection of reduced ejection fraction were higher in women and older persons and were different between the two assays.
Journal ArticleDOI

Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991.

TL;DR: In this paper, the authors evaluated all patients receiving a first diagnosis of congestive heart failure in Olmsted County, Minnesota, in 1991 (n=216) and found that the prognosis of patients with a new diagnosis of CHF was poor; survival was 86±2% at 3 months, 76±3% at 1 year, and 35±3%.